Skip to main content
. 2012 Oct 23;12:894. doi: 10.1186/1471-2458-12-894

Table 3.

Data and analysis France, part 1

Alter 2004 2050 2004 in % 2050 in % Pharma Expenses 1997 Partial Expenses 2004 Partial Expenses 2050 Change Expenses
0-9
7279,22
8658,88
12,15%
11,60%
210,44 €
25,58 €
24,41 €
-4,57%
10-19
7612,54
8513,59
12,71%
11,40%
143,91 €
18,29 €
16,41 €
-10,28%
20-29
7643,13
8306,88
12,76%
11,13%
222,42 €
28,38 €
24,75 €
-12,81%
30-39
8602,58
8583,24
14,36%
11,50%
310,69 €
44,63 €
35,72 €
-19,95%
40-49
8482,64
8176,95
14,16%
10,95%
411,76 €
58,32 €
45,10 €
-22,66%
50-59
7797,79
7787,49
13,02%
10,43%
770,93 €
100,37 €
80,42 €
-19,88%
60-69
5198,12
7813,66
8,68%
10,47%
1084,67 €
94,14 €
113,53 €
20,59%
70-79
4611,94
7219,29
7,70%
9,67%
1592,33 €
122,61 €
153,98 €
25,58%
>79
2665,04
9594,43
4,45%
12,85%
1613,83 €
71,81 €
207,41 €
188,83%
SUM 59893,00 74654,40 100,00% 100,00%   564,13 € 701,73 € 24,39%

Source: Own analysis based on [4,16].